| Dr Matt Perdue, MD | |
|
27 N 27th St Ste 21e, Billings, MT 59101-2373 | |
| (406) 200-8471 | |
| (833) 465-3766 |
| Full Name | Dr Matt Perdue |
|---|---|
| Gender | Male |
| Speciality | Psychiatry |
| Experience | 9 Years |
| Location | 27 N 27th St Ste 21e, Billings, Montana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1801349410 | NPI | - | NPPES |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Frontier Psychiatry Pllc | 7315378874 | 21 |
News Archive
Neuralstem, Inc. announced that the final patient was treated in its Phase II trial using NSI-566 spinal cord-derived neural stem cells in the treatment of amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease).
The protocol used to treat the first known survivor of rabies without prior vaccination is published in the June 16, 2005, issue of the New England Journal of Medicine. It is hoped that this approach can be replicated, tested, and provide a guide for treating this fatal condition, especially in parts of the world where the incidence of rabies is rampant.
A researcher at the Cancer Therapy & Research Center is the leader on a study receiving a special $1.62 million orphan disease grant from the Food & Drug Administration.
Michigan State University researchers are studying the role that statins - lifesavers for tens of millions of Americans trying to lower their cholesterol - play in causing disabling tendon ruptures.
BiondVax Pharmaceuticals Ltd. announced today that the National Authority for Technological Innovation, formerly known as the Office of the Chief Scientist, agreed to fund up to 40% of a NIS 3.6 million (US$920,000) project towards ongoing development of the Company's Universal Flu Vaccine.
› Verified 3 days ago
| Entity Name | Frontier Psychiatry Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1508493156 PECOS PAC ID: 7315378874 Enrollment ID: O20200518000234 |
News Archive
Neuralstem, Inc. announced that the final patient was treated in its Phase II trial using NSI-566 spinal cord-derived neural stem cells in the treatment of amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease).
The protocol used to treat the first known survivor of rabies without prior vaccination is published in the June 16, 2005, issue of the New England Journal of Medicine. It is hoped that this approach can be replicated, tested, and provide a guide for treating this fatal condition, especially in parts of the world where the incidence of rabies is rampant.
A researcher at the Cancer Therapy & Research Center is the leader on a study receiving a special $1.62 million orphan disease grant from the Food & Drug Administration.
Michigan State University researchers are studying the role that statins - lifesavers for tens of millions of Americans trying to lower their cholesterol - play in causing disabling tendon ruptures.
BiondVax Pharmaceuticals Ltd. announced today that the National Authority for Technological Innovation, formerly known as the Office of the Chief Scientist, agreed to fund up to 40% of a NIS 3.6 million (US$920,000) project towards ongoing development of the Company's Universal Flu Vaccine.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Matt Perdue, MD 27 N 27th St Ste 21e, Billings, MT 59101-2373 Ph: (406) 200-8471 | Dr Matt Perdue, MD 27 N 27th St Ste 21e, Billings, MT 59101-2373 Ph: (406) 200-8471 |
News Archive
Neuralstem, Inc. announced that the final patient was treated in its Phase II trial using NSI-566 spinal cord-derived neural stem cells in the treatment of amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease).
The protocol used to treat the first known survivor of rabies without prior vaccination is published in the June 16, 2005, issue of the New England Journal of Medicine. It is hoped that this approach can be replicated, tested, and provide a guide for treating this fatal condition, especially in parts of the world where the incidence of rabies is rampant.
A researcher at the Cancer Therapy & Research Center is the leader on a study receiving a special $1.62 million orphan disease grant from the Food & Drug Administration.
Michigan State University researchers are studying the role that statins - lifesavers for tens of millions of Americans trying to lower their cholesterol - play in causing disabling tendon ruptures.
BiondVax Pharmaceuticals Ltd. announced today that the National Authority for Technological Innovation, formerly known as the Office of the Chief Scientist, agreed to fund up to 40% of a NIS 3.6 million (US$920,000) project towards ongoing development of the Company's Universal Flu Vaccine.
› Verified 3 days ago
James Frederick Richards, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1233 N 30th St, Billings, MT 59101 Phone: 406-237-3850 Fax: 406-237-3855 | |
Tiffany White, D.O. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 2800 10th Ave N, Billings, MT 59101 Phone: 406-238-2500 | |
Dr. Alfred Estin Avery, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 2807 1st Ave N, Billings, MT 59101 Phone: 406-896-0483 Fax: 406-259-9479 | |
Martha Lorena Cruz, DO Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 801 N 29th St, Billings, MT 59101 Phone: 406-238-2500 | |
Dale M. Peterson, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 2825 8th Ave N, Billings, MT 59101 Phone: 406-238-2500 | |
Christopher Evan Stewart, Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 801 N 29th St, Billings, MT 59101 Phone: 406-238-2500 | |
John G. Denegre, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 1020 N 27th St, Billings, MT 59101 Phone: 406-238-2500 |